If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,978.00    -6.00 (-0.20%)
Bid:
2,995.00
Ask:
2,999.00
Spread: 4.00 (0.134%)
Market Cap: £4.15b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

29 Mar 2010 16:53

RNS Number : 3706J
Croda International PLC
29 March 2010
Β 

ο»Ώ

Annex DTR3

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

All relevant boxes should be completed in block capital letters.

Β 

1.

Name of the issuer

Β 

CRODA INTERNATIONAL PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

(i)

Β 

3.

Name of person discharging managerial

responsibilities/director

Β 

DAVID EDWARD BARRACLOUGH

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

RELATES TO PDMR

Β 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non beneficial

interest

Β 

HOLDING OF DAVID EDWARD BARRACLOUGH

Β 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES OF 10P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

DAVID EDWARD BARRACLOUGH

8.

State the nature of the transaction

Β 

EXERCISE ON 26 MARCH 2010 OF A NIL COST AWARD GRANTED ON 22 FEBRUARY 2007 UNDER THE CRODA INTERNATIONAL LONG-TERM INCENTIVE PLAN OVER 16,365 SHARES.

Β 

EXERCISE ON 26 MARCH 2010 OF AN OPTION GRANTED ON 5 MARCH 2003 UNDER THE CRODA SENIOR EXECUTIVE SHARE OPTION SCHEME OVER 44,130 SHARES AT AN OPTION PRICE OF 230P.

Β 

SALE OF 40,821 SHARES ON 26 MARCH 2010.

Β 

9.

Number of shares, debentures or financial

instruments relating to shares acquired

Β 

60,495

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

LESS THAN 0.1%

Β 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

Β 

40,821

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

LESS THAN 0.1%

Β 

13.

Price per share or value of transaction

Β 

LTIP AWARD EXERCISE PRICE PER SHARE - NIL

SENIOR EXECUTIVE OPTION PRICE PER SHARE - Β£2.30

SALE PRICE PER SHARE - Β£9.505797

Β 

14.

Date and place of transaction

Β 

26 MARCH 2010

Β 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

107,230 - LESS THAN 0.1%

Β 

16.

Date issuer informed of transaction

Β 

26 MARCH 2010

Β 

Β 

Β 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

Β 

17.

Date of grant

Β 

Β 

18.

Period during which or date on which exercisable

Β 

Β 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

Β 

Β 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

Β 

Β 

22.

Total number of shares or debentures over which options held following notification

Β 

23.

Any additional information

Β 

NUMBER OF ORDINARY SHARES IN ISSUE, EXCLUDING SHARES HELD IN TREASURY: 137,312,439

Β 

24.

Name of contact and telephone number for queries

Β 

MRS D S HILL - 01405 860551

Β 

Name of authorised official of issuer responsible for making notification

Β 

Date of notification 29 MARCH 2010

Β 

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSEKLFLBXFEBBL
Date   Source Headline
11th Jun 20262:58 pmRNSDirector/PDMR Shareholding
11th Jun 20269:15 amRNSDirector Declaration
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.